What is EXOSYSTEMS?
Founded in 2017 and headquartered in Seoul, South Korea, EXOSYSTEMS operates at the intersection of artificial intelligence and digital healthcare. The company leverages AI to develop innovative solutions aimed at transforming healthcare delivery and patient outcomes. Its establishment in 2017 positions it as a relatively young but ambitious player in a market increasingly reliant on technological advancements for efficiency and efficacy. The company's focus on AI-driven healthcare solutions suggests a commitment to leveraging cutting-edge technology to address complex health challenges.
How much funding has EXOSYSTEMS raised?
EXOSYSTEMS has raised a total of $3.9M across 1 funding round:
Series A
$3.9M
Series A (2021): $3.9M with participation from Korea Technology Finance, Laguna Investment, and SBI Investment Korea
Key Investors in EXOSYSTEMS
Korea Technology Finance
Korea Technology Finance is a government-backed institution focused on providing financial support and guarantees to technology-based startups and SMEs, aiming to foster innovation and business growth through various financial instruments and digital platforms.
Laguna Investment
Laguna Investment LLC is a real estate investment company specializing in identifying and acquiring distressed properties for fix-and-flip or cashflow generation, focusing on off-market deals and properties at significant discounts.
SBI Investment Korea
SBI Investment Korea is a venture capital firm that invests in seed and growth-stage companies, with a particular focus on the Fintech sector, offering financial and management advisory services in exchange for equity.
What's next for EXOSYSTEMS?
With the recent major strategic investment, EXOSYSTEMS is poised for accelerated growth and expansion. The substantial enterprise-level funding indicates a strong validation of the company's business model and technological capabilities. This capital injection will likely fuel further research and development, enhance product offerings, and support market penetration efforts. The strategic nature of the investment suggests that the backers are not only providing financial resources but also potentially offering valuable industry expertise and network access to help EXOSYSTEMS scale its operations and solidify its position in the competitive digital healthcare landscape.
See full EXOSYSTEMS company page
